Abstract: Aspects of the disclosure are directed to a system for classifying software as malicious or benign based on predicting the effect the software has on the platform before the software is actually deployed. A system as described herein can operate in close to real-time to receive, isolate, and classify software as benign or malicious. Aspects of the disclosure provide for accurate classification of malicious programs or scripts even if ostensibly the program appears benign, and vice versa, based on the effect predicted by a machine learning model trained as described herein. The system can also be implemented to isolate and verify incoming scripts or software to the platform, to provide a predicted classification while not substantially impacting processing pipelines involving platform resources or the user experience with the platform in general.

Abstract: Examples of molded substrates are described herein. In some examples, a molded substrate may support integrated circuitry. In some examples, the molded substrate and the integrated circuitry are included in a circuitry package for a replaceable print component. In some examples, the molded substrate is relatively flat. In some examples, molding remnants may be on the molded substrate.

Abstract: Examples of molded substrates are described herein. In some examples, a molded substrate may support integrated circuitry. In some examples, the molded substrate and the integrated circuitry are included in a circuitry package for a replaceable print component. In some examples, the molded substrate is relatively flat. In some examples, molding remnants may be on the molded substrate.

Abstract: Aspects of the disclosure are directed to a system for classifying software as malicious or benign based on predicting the effect the software has on the platform before the software is actually deployed. A system as described herein can operate in close to real-time to receive, isolate, and classify software as benign or malicious. Aspects of the disclosure provide for accurate classification of malicious programs or scripts even if ostensibly the program appears benign, and vice versa, based on the effect predicted by a machine learning model trained as described herein. The system can also be implemented to isolate and verify incoming scripts or software to the platform, to provide a predicted classification while not substantially impacting processing pipelines involving platform resources or the user experience with the platform in general.

Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.

Abstract: In embodiments, an underwater wire saw comprises a frame, one or more arms connected to the frame with a predetermined number of the arms comprising a wire tensioner and a selectively telescoping or collapsing tube within a tube, and a continuous wire guided by a plurality of wire guides and tensioned using the wire tensioner. The underwater wire saw may further comprise a clamp.

Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.

Abstract: In embodiments, an underwater wire saw comprises a frame, one or more arms connected to the frame with a predetermined number of the arms comprising a wire tensioner and a selectively telescoping or collapsing tube within a tube, and a continuous wire guided by a plurality of wire guides and tensioned using the wire tensioner. The underwater wire saw may further comprise a clamp.

Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.

Abstract: The present invention teaches a filament yarn that has low wicking, i.e., less than or equal to about 6 mm; has a contact angle of greater than or equal to about 65° but less than about 90° according to the straw method; and a static voltage of +/?400 volts (between ?400 to +400 volts). Such yarns are traditionally employed in weaving signs, banners, awning, tents and other products where moisture resistant yarn is important. The yarns can be made into fabrics that possess the same features as the yarn, namely low wicking, and water and oil repellency.

Abstract: This invention relates to a process for the separation of a metal complex catalyst and any free ligand which may be present, from a homogeneous organic synthesis reaction mixture using sub-nanoporous, chemically stable membranes having discrete pores which allow organic products and by-products to pass through the membrane as permeate while retaining substantially all of the metal complex catalyst and free ligand, if any, as retentate.